Kate R. Pawloski, MD, MPH
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
Conditions I Treat
- Breast cancers and conditions
- Lobular carcinoma in situ (LCIS)
My Specialties
- Cancer prevention
- Risk assessment
- Lumpectomy
Get to Know Me
I am a breast surgeon who specializes in the treatment of breast cancer and high-risk benign lesions. I see patients at the Evelyn H. Lauder Breast Center in New York City. I perform all types of breast surgery, including:
- Lumpectomy (breast conservation)
- Simple mastectomy
- Nipple-sparing mastectomy
- Total mastectomy with aesthetic flat closure—a type of reconstructive surgery for the chest wall for women who choose to go flat.
- Sentinel lymph node biopsy
- Axillary lymph node dissection
My clinical and research interests focus on individualized risk assessment and management. I am dedicated to empowering my patients with knowledge about their risk and exploring tailored strategies for prevention. My goal is to ensure that all of my patients and their loved ones are fully informed of their options and feel confident in navigating every step of their care.
In collaboration with my colleagues in medical oncology, radiation oncology, plastic surgery, radiology, and pathology, I aim to provide high-quality, compassionate care that is tailored to the unique needs of each person.
I'm a breast surgeon, which is a doctor with special training in breast surgery.
- Assistant Attending Surgeon
Conditions I Treat
- Breast cancers and conditions
- Lobular carcinoma in situ (LCIS)
My Specialties
- Cancer prevention
- Risk assessment
- Lumpectomy
- Total mastectomy
- Nipple-sparing mastectomy
- Sentinel lymph node biopsy
- Axillary lymph node dissection (ALND)
Education
- MD, Rutgers Robert Wood Johnson Medical School
- MPH, Icahn School of Medicine at Mount Sinai
Residencies
- General Surgery, Icahn School of Medicine at Mount Sinai
- Preventive Medicine & Public Health, Icahn School of Medicine at Mount Sinai
Fellowships
- Breast Surgical Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- American Board of Surgery
- American Board of Preventive Medicine
Awards and Honors
- Breast Cancer Alliance, Veronica Beard Fellowship (2023)
- Alpha Omega Alpha Honor Society (2021)
- American Cancer Society Physician Training Award (2019)
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
HMO, EPO PPO, POS, Transplant
In Network Coverage Type
PPO
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
POS, EPO, HMO
In Network Coverage Type
State Government
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
State Government
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO EPO
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
TBD
In Network Coverage Type
PPO, POS, EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
HMO
City Employee Health Plans (Gold and Gold Care)
In Network Coverage Type
Supplemental
In Network Coverage Type
PPO/OAP
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
HMO/EPO
In Network Coverage Type
PPO, EPO
In Network Coverage Type
State Government
In Network Coverage Type
PPO, POS, HMO
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO, POS
In Network Coverage Type
PPO, POS, HMO
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Pawloski KR, Barrio AV. Breast surgery after neoadjuvant systemic therapy. Transl Breast Cancer Res. 2024 Mar 4;5:13. doi: 10.21037/tbcr-23-50. PMID: 38751679; PMCID: PMC11093099.
Pawloski KR, Srour MK, Moo TA, Sevilimedu V, Nelson JA, Garcia P, Kirstein LJ, Morrow M, Tadros AB. Timing of Chemotherapy and Patient-Reported Outcomes After Breast-Conserving Surgery and Mastectomy with Immediate Reconstruction. Ann Surg Oncol. 2023 May;30(5):2897-2909. doi: 10.1245/s10434-023-13148-5. Epub 2023 Feb 3. PMID: 36737530; PMCID: PMC11110643.
Palmquist E, Limberg J, Chu JJ, White C, Baser RE, Sevilimedu V, Pawloski KR, Garcia P, Nelson JA, Moo TA, Morrow M, Tadros AB. Patient-Reported Outcome Measures for Patients Who Have Clinical T4 Breast Cancer Treated via Mastectomy with and Without Reconstruction. Ann Surg Oncol. 2023 Jan;30(1):115-121. doi: 10.1245/s10434-022-12560-7. Epub 2022 Sep 23. PMID: 36149609; PMCID: PMC10128102.
Pak LM, Pawloski KR, Sevilimedu V, Kalvin HL, Le T, Tokita HK, Tadros A, Morrow M, Van Zee KJ, Kirstein LJ, Moo TA. How Much Pain Will I Have After Surgery? A Preoperative Nomogram to Predict Acute Pain Following Mastectomy. Ann Surg Oncol. 2022 Oct;29(11):6706-6713. doi: 10.1245/s10434-022-11976-5. Epub 2022 Jun 14. PMID: 35699814; PMCID: PMC9196152.
Pawloski KR, Barrio AV, Gemignani ML, Sevilimedu V, Le T, Dayan J, Morrow M, Tadros AB. Reconstruction in Women with T4 Breast Cancer after Neoadjuvant Chemotherapy: When Is It Safe? J Am Coll Surg. 2021 Aug;233(2):285-293. doi: 10.1016/j.jamcollsurg.2021.04.016. Epub 2021 May 3. PMID: 33957258; PMCID: PMC9466002.
Pawloski KR, Christian N, Knezevic A, Wen HY, Van Zee KJ, Morrow M, Tadros AB. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia. Breast Cancer Res Treat. 2020 Dec;184(3):873-880. doi: 10.1007/s10549-020-05890-1. Epub 2020 Aug 28. PMID: 32857242; PMCID: PMC7657999.
Visit PubMed for a full listing of Dr. Pawloski’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Members of the MSK Community often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community. These activities outside of MSK further our mission, provide productive collaborations, and promote the practical application of scientific discoveries.
MSK requires doctors, faculty members, and leaders to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public. Not all disclosed interests and relationships present conflicts of interest. MSK reviews all disclosed interests and relationships to assess whether a conflict of interest exists and whether formal COI management is needed.
Kate R. Pawloski discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2024 through disclosure submission in spring 2025). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].